Spravato
Articles tagged with “Spravato”
CBT After Esketamine Cuts Relapse Risk, Trial Finds
The CBT-ENDURE trial found that pairing esketamine with 16 weeks of CBT reduced suicidal ideation and depression severity better than esketamine alone.
Ketamine Side Effects: What the Data Now Shows
New clinical guidance on NMDA antagonist side effects and discontinuation rates gives ketamine patients a clearer picture of what to expect and when to switch.
Ketamine vs. Esketamine: Side Effects and Who Stops Treatment
New clinical guidance on NMDA antagonist side effects and dropout rates helps patients make smarter choices about ketamine-based depression treatment.
Ketamine for TRD Works Better When Clinics Measure It
New research highlights how symptom tracking and dose optimization help treatment-resistant depression patients reach remission faster with ketamine.
Esketamine's Role in Treatment-Resistant Depression
Esketamine (Spravato) for treatment-resistant depression: how it works, who qualifies, REMS clinic visits, cost ranges, and Spravato vs IV ketamine.
Esketamine vs Racemic Ketamine: Understanding the Difference
Esketamine (Spravato) vs racemic ketamine compared: enantiomer differences, FDA status, efficacy, side effects, insurance coverage, and access for patients.
Racemic Ketamine vs Esketamine: Pharmacological Comparison
Racemic ketamine vs esketamine pharmacology: NMDA binding, half-life, dose equivalence, side effect profile, cost per session, and clinical decision points.
Does Insurance Cover Ketamine Treatment?
A clear guide to insurance coverage for ketamine therapy, including Spravato, off-label IV infusions, and compounded formulations — plus tips for navigating coverage.
IV vs Oral vs Nasal Ketamine: Comparing Treatment Methods
IV, oral/sublingual, and intranasal ketamine compared by bioavailability, onset, monitoring time, cost per session, and what each route is typically used for.
How Much Does Ketamine Therapy Cost?
A comprehensive breakdown of ketamine therapy costs by treatment type — IV infusion, Spravato, compounded formulations, and at-home options — plus factors that affect price.
Esketamine: The S-Enantiomer Behind Spravato
A glossary entry on esketamine, the S-enantiomer of ketamine marketed as Spravato, covering its pharmacology, FDA approval, and clinical significance.
FDA Esketamine (Spravato) Updates
A summary of the latest FDA regulatory actions, label updates, and clinical developments related to esketamine (Spravato) for depression treatment.
Ketamine Insurance Coverage: 2025 Trends and Developments
Ketamine insurance coverage in 2025: Spravato payer trends, off-label IV claim outcomes, prior-auth patterns, and what coverage gaps patients still face.
Intranasal Ketamine and Esketamine (Spravato)
Intranasal ketamine and FDA-approved Spravato (esketamine): how dosing works, the REMS clinic visit, side effects, insurance coverage, and what to expect.
Contact Ketamine Resource
Send corrections, partnership questions, or advertising inquiries.